Rs 1,900 Puts — 1.8% Below Current Price — Draw 2,050 Contracts on Sun Pharmaceutical Industries Ltd

Put Options Event and Cash Market Context

The most active put strikes for Sun Pharmaceutical Industries Ltd on 9 July were Rs 1,900 and Rs 1,920, with 2,050 and 2,255 contracts traded respectively. The Rs 1,920 strike saw a turnover of ₹224.78 lakhs, while the Rs 1,900 strike accounted for ₹151.82 lakhs. Open interest at these strikes stands at 1,653 and 1,728 contracts, indicating that much of the activity represents fresh positioning rather than mere rollovers or adjustments.

The underlying stock price at Rs 1,934.20 is currently trading above both these put strikes, with the Rs 1,900 strike approximately 1.8% out-of-the-money (OTM) and the Rs 1,920 strike about 0.7% OTM. This proximity to the current price is a critical factor in interpreting the intent behind the put activity — is this hedging, a bearish bet, or put writing?

Strike Price Analysis: Moneyness and Intent

The Rs 1,900 and Rs 1,920 put strikes are both OTM but close to the money, suggesting that buyers are seeking protection against a modest pullback rather than a sharp decline. The Rs 1,900 strike, being 1.8% below the current price, aligns with a near-term support zone, while the Rs 1,920 strike is even closer, just 0.7% below the market price.

Given the stock recently reached a 52-week high of Rs 1,933.60 and is trading above all major moving averages — 5-day, 20-day, 50-day, 100-day, and 200-day — the put strikes appear positioned as a buffer against a potential short-term correction rather than a bet on a sustained downtrend. This is consistent with protective hedging, where investors lock in downside protection while maintaining their long exposure.

Interpreting the Put Activity: Hedging, Bearish Positioning, or Put Writing?

Put option activity can be ambiguous. The three primary interpretations are: directional bearish bets (put buying anticipating a decline), hedging of existing long positions (protection against downside risk), or put writing (selling puts to collect premium, implying bullish or neutral outlook).

In this case, the stock’s recent upward momentum and the OTM nature of the puts suggest hedging is the dominant motive. If the puts were ITM or ATM and the stock was falling, bearish positioning would be more plausible. Conversely, put writing typically involves strikes further OTM with high premium collection and stable or rising open interest, which is not strongly evident here given the fresh contracts traded and turnover.

The ratio of contracts traded to open interest is roughly 1.2:1 for both strikes, indicating significant fresh buying rather than just rollovers or writing. This supports the view that investors are actively seeking downside protection amid a rally — should investors consider similar hedging strategies?

Open Interest and Contracts Analysis

The open interest at Rs 1,900 and Rs 1,920 strikes stands at 1,728 and 1,653 contracts respectively, slightly below the number of contracts traded on the day. This suggests a net increase in open interest, pointing to fresh positions being established rather than closing out existing ones.

Such fresh buying of puts near the money, combined with the stock’s recent gains, is more indicative of investors seeking downside insurance rather than outright bearish bets. The turnover figures of ₹151.82 lakhs and ₹224.78 lakhs at these strikes also reflect significant premium paid, consistent with protective put buying rather than premium collection through writing.

Cash Market Context: Momentum and Moving Averages

Sun Pharmaceutical Industries Ltd has outperformed its sector by 1.08% today, gaining 2.43% against the sector’s 1.78% and the Sensex’s 0.66%. The stock has reversed a two-day decline and touched a new 52-week high of Rs 1,933.60. It trades above all key moving averages, signalling strong technical momentum.

Delivery volumes rose sharply by 67.14% to 15.71 lakh shares on 8 July, indicating robust investor participation in the rally. However, the put activity suggests some investors are cautious, possibly anticipating a short-term pullback or seeking to protect profits in a volatile environment — does this cautiousness signal a pause or consolidation ahead?

Delivery Volume and Quality of Participation

The increase in delivery volume alongside the stock’s rise points to genuine buying interest rather than speculative intraday moves. This lends credibility to the rally and supports the interpretation that put buying is more likely protective hedging than a sign of impending weakness.

In markets where delivery volumes are thin, put buying can sometimes signal fear of a sharp correction. Here, the strong delivery participation tempers that view, suggesting investors are managing risk prudently rather than expecting a collapse.

Conclusion: Protective Hedging Dominates Put Activity

The Rs 1,900 and Rs 1,920 put strikes on Sun Pharmaceutical Industries Ltd have attracted significant fresh buying ahead of the 28 July 2026 expiry. Given the stock’s recent rally to a 52-week high, strong delivery volumes, and positioning above all major moving averages, the most plausible interpretation is that investors are employing these puts as a hedge against a near-term pullback rather than signalling outright bearish conviction.

While the possibility of directional bearish bets cannot be entirely ruled out, the data points more strongly to protective strategies. The proximity of the strikes to the current price and the fresh open interest support this view. Put writing appears less likely given the premium paid and turnover figures.

With the stock’s technical momentum intact but some caution evident in options activity, should investors consider hedging their positions or view this as a signal to hold?

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today